These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10164053)

  • 21. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.
    Camenzind E; Steg PG; Wijns W
    Circulation; 2007 Mar; 115(11):1440-55; discussion 1455. PubMed ID: 17344324
    [No Abstract]   [Full Text] [Related]  

  • 22. Stent coatings and local drug delivery; state of the art.
    Gunn J; Cumberland D
    Eur Heart J; 1999 Dec; 20(23):1693-700. PubMed ID: 10562476
    [No Abstract]   [Full Text] [Related]  

  • 23. [Benefits and risks of drug-eluting stents].
    Zijlstra F
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1005-7. PubMed ID: 17508683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
    Pendyala L; Jabara R; Robinson K; Chronos N
    J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel injectable pH and temperature sensitive block copolymer hydrogel.
    Shim WS; Yoo JS; Bae YH; Lee DS
    Biomacromolecules; 2005; 6(6):2930-4. PubMed ID: 16283710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late thrombosis a concern with drug-eluting stents.
    Leon MB
    J Interv Cardiol; 2007 Feb; 20(1):26-9. PubMed ID: 17300394
    [No Abstract]   [Full Text] [Related]  

  • 29. TCT Daily: safety profile of drug-eluting stents similar to bare-metal stents: lower restenosis rates associated with DES.
    Kahn J
    J Interv Cardiol; 2007 Feb; 20(1):30-1. PubMed ID: 17300395
    [No Abstract]   [Full Text] [Related]  

  • 30. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar].
    Hansen PR
    Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous subacute stent thrombosis of two drug-eluting stents in the left anterior descending and the circumflex coronary arteries. Case report and review of the literature.
    Movahed MR; Vu J; Ahsan C
    J Invasive Cardiol; 2006 Jul; 18(7):E198-202. PubMed ID: 16816448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of a novel hydrogel-based intelligent system for controlled drug release.
    He H; Cao X; Lee LJ
    J Control Release; 2004 Mar; 95(3):391-402. PubMed ID: 15023451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organo hydrogel hybrids. Formation of reservoirs for protein delivery.
    Nederberg F; Watanabe J; Ishihara K; Hilborn J; Bowden T
    Biomacromolecules; 2005; 6(6):3088-94. PubMed ID: 16283731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal stent design for drug delivery.
    Rogers CD
    Rev Cardiovasc Med; 2004; 5 Suppl 2():S9-S15. PubMed ID: 15184829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local vascular toxicokinetics of stent-based drug delivery.
    Tesfamariam B
    Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coated stents: local pharmacology.
    Raman VK; Edelman ER
    Semin Interv Cardiol; 1998; 3(3-4):133-7. PubMed ID: 10406682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.
    Kimura M; Takai M; Ishihara K
    J Biomed Mater Res A; 2007 Jan; 80(1):45-54. PubMed ID: 16958047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late stent thrombosis: a not negligible issue after drug-eluting stent implantation.
    Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):531-2. PubMed ID: 17442197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.